Information on the relevance and impact of the 3 key electrolytes sodium, magnesium and calcium in the context of patients treated with Veltassa®.

A reminder of the key facts and figures around the prevalence of hyperkalemia and how important it is to control serum K⁺ levels to enable patients with chronic kidney disease and/or heart failure to stay on guideline-recommended therapy.

Concise summaries of AMETHYST-DN, OPAL-HK, PEARL-HF and AMBER, providing details on study design, patient population, efficacy and safety endpoints.

A more in-depth look at how Veltassa® works.

Concise information on dosing and the flexibility of Veltassa®to take with liquids and foods.

Summary of the ESC guidelines for the recommendation of Veltassa®.

A visual guide on how to take Veltassa® and a helpful chart to note when the dose was taken so that other medicines are not taken within the precautionary 3-hour period.

A simple means to help you share key information about hyperkalemia with your patients. It includes a description of hyperkalemia, who is at risk, symptoms and treatments, and tips for a low-potassium diet. A chart is also provided that may help patients learn about low- and high-potassium foods.

Your guide to a low-potassium diet
A brochure to help you educate your patients on the correct diet choices for a low-potassium lifestyle. The brochure outlines high- and low-potassium foods, as well as other tips for adhering to a low-potassium diet.

A brochure to help you educate patients on the possible severe consequences of hyperkalemia. The brochure provides essential information for patients about hyperkalemia, including its causes, symptoms, treatment options, and the role of diet.

A brochure for your patients summarising high potassium and how to manage hyperkalemia.

A short summary on what your patient needs to know about hyperkalemia.